Proteomics International Laboratories Ltd
ASX:PIQ
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.565
1.34
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PIQ stock under the Base Case scenario is 0.53 AUD. Compared to the current market price of 0.66 AUD, Proteomics International Laboratories Ltd is Overvalued by 20%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Proteomics International Laboratories Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PIQ cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Proteomics International Laboratories Ltd
Balance Sheet Decomposition
Proteomics International Laboratories Ltd
Current Assets | 9.2m |
Cash & Short-Term Investments | 6.6m |
Receivables | 269.3k |
Other Current Assets | 2.3m |
Non-Current Assets | 1.7m |
PP&E | 1.7m |
Intangibles | 1k |
Current Liabilities | 905k |
Accounts Payable | 57.6k |
Other Current Liabilities | 847.4k |
Non-Current Liabilities | 557.6k |
Long-Term Debt | 221k |
Other Non-Current Liabilities | 336.6k |
Earnings Waterfall
Proteomics International Laboratories Ltd
Revenue
|
1.4m
AUD
|
Operating Expenses
|
-7.9m
AUD
|
Operating Income
|
-6.5m
AUD
|
Other Expenses
|
74.7k
AUD
|
Net Income
|
-6.4m
AUD
|
Free Cash Flow Analysis
Proteomics International Laboratories Ltd
AUD | |
Free Cash Flow | AUD |
PIQ Profitability Score
Profitability Due Diligence
Proteomics International Laboratories Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
Proteomics International Laboratories Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
PIQ Solvency Score
Solvency Due Diligence
Proteomics International Laboratories Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Proteomics International Laboratories Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PIQ Price Targets Summary
Proteomics International Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for PIQ is 0.51 AUD with a low forecast of 0.51 AUD and a high forecast of 0.53 AUD.
Dividends
Current shareholder yield for PIQ is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
PIQ Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2015-04-16. The firm is engaged in predictive diagnostics and bio-analytical services. The firm specializes in proteomics, the study of the structure and function of proteins. The firm focuses on developing and commercializing diagnostic tests for chronic diseases. The firm operates in three business units unified by a technology platform: PromarkerD, Diagnostics and Analytical Services. PromarkerD is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes. Diagnostics includes Promarker platform, used to discover, verify, and analytically validate the panel of protein biomarkers for diabetic kidney disease. Analytical Services includes proteomics-based technology platform, used to test, and validate the protein composition of a wide and varied range of products.
Contact
IPO
Employees
Officers
The intrinsic value of one PIQ stock under the Base Case scenario is 0.53 AUD.
Compared to the current market price of 0.66 AUD, Proteomics International Laboratories Ltd is Overvalued by 20%.